Bank of America Merrill Lynch Halves CannTrust Price Target to US$3.50

CannTrust Holdings (TSX: TRST) (NYSE:CTST) has begun to see fallout from this mornings announcement that it had been growing cannabis illegally in unlicensed grow rooms at its Pelham, Ontario Facility.

While the share price continues to suffer, analysts have begun to downgrade the equity as a result of their actions. Bank of America Merrill Lynch has downgraded their price target from US$7.00 to that of US$3.50 as a result of the public relations nightmare. They also changed their rating from “Buy” to “Underperform”.

Due to uncertainty on go-forward financials, exacerbated by likely diminishing investor confidence, we see shares remaining weak

Christopher Carey, Analyst

The downgrade is noteworthy considering Bank of America was one of the lead book-running agents for CannTrust’s recent US$170 million financial raise that closed at the beginning of May. The raise was associated with a base shelf prospectus filed March 19, 2019, a time during which the illegal activity was occurring.

BofA had reaffirmed their price target on CannTrust just a few weeks ago, stating that the firms assets were “under appreciated” by investors.

CannTrust is currently trading at US$3.90, down 21.05% on the day following this mornings news.


Information for this briefing was found via BNN Bloomberg and CannTrust Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Related News

Canntrust Holdings Settles With Former Danish Partner Stenocare

Canntrust Holdings (TSX: TRST) (NYSE: CTST) has finally settled with Stenocare of Denmark in relation...

Monday, January 13, 2020, 11:56:13 AM

CannTrust Nailed for Selling Unlicensed Product

This morning CannTrust announced a bombshell for the cannabis industry. The Company put out in...

Monday, July 8, 2019, 08:14:59 AM

Early-Stage Interest Allegedly Exists for Canntrust Assets

Canntrust Holdings (TSX: TRST) (NYSE: CTST) allegedly has parties interested in purchasing its assets, according...

Thursday, July 18, 2019, 03:44:31 PM

CannTrust to be Dropped From the S&P/TSX Composite

Yesterday the Globe and Mail reported that CannTrust Holdings is expected to be dropped from...

Tuesday, September 3, 2019, 09:02:28 AM

CannTrust Facing Ontario Securities Commission Investigation

CannTrust has announced they expect to be late filing their earnings, in a Tuesday evening...

Thursday, August 1, 2019, 06:37:56 PM